Cigna Group (NYSE:CI – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as $311.98 and last traded at $312.3050, with a volume of 294,103 shares changing hands. The stock had previously closed at $304.37.
Analyst Ratings Changes
A number of equities analysts recently weighed in on the stock. Jefferies Financial Group lowered shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Guggenheim lifted their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, September 26th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a research report on Thursday, October 1st. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of Cigna Group in a research report on Friday, October 2nd. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and a consensus target price of $338.24.
Get Our Latest Research Report on CI
Cigna Group Stock Up 3.5%
The business has a 50-day moving average price of $280.49 and a 200 day moving average price of $282.73. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $83.24 billion, a P/E ratio of 13.03, a P/E/G ratio of 1.03 and a beta of 0.29.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $71.56 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the previous year, the business posted $7.20 earnings per share. Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts expect that Cigna Group will post 30.50 EPS for the current fiscal year.
Insiders Place Their Bets
In other Cigna Group news, insider Nicole Jones sold 19,436 shares of Cigna Group stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 22,730 shares of company stock valued at $6,293,359 over the last three months. Corporate insiders own 0.60% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. GQG Partners LLC bought a new stake in Cigna Group during the second quarter worth approximately $1,628,918,000. Bank of America Corp DE purchased a new stake in Cigna Group during the second quarter valued at approximately $827,692,000. Legal & General Group Plc bought a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $542,779,000. The Manufacturers Life Insurance Company bought a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $241,312,000. Finally, BlackRock Inc. lifted its stake in shares of Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
About Cigna Group
The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.
The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.
Recommended Stories
- Five stocks we like better than Cigna Group
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
